NCT06117930 Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience Research
| NCT ID | NCT06117930 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Malignant Central Nervous System Neoplasm |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-02-28 |
| Primary Completion | 2029-12-13 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-02-28 with a primary completion date of 2029-12-13.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study explores how microorganisms in the gut can affect the growth and progression of brain tumors.
Eligibility Criteria
Inclusion Criteria: * All patients undergoing resection for a tumor of the central nervous system and associated controls are eligible to participate in this study. Exclusion Criteria: * Excluded samples will be from patients younger than 18 years old. There are no exclusions due to race/sex.
Contact & Investigator
Alfredo Quinones-Hinojosa, M.D.
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT06117930 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Malignant Central Nervous System Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06117930 currently recruiting?
Yes, NCT06117930 is actively recruiting participants. Contact the research team at mayocliniccancerstudies@mayo.edu for enrollment information.
Where is the NCT06117930 trial being conducted?
This trial is being conducted at Jacksonville, United States.
Who is sponsoring the NCT06117930 clinical trial?
NCT06117930 is sponsored by Mayo Clinic. The principal investigator is Alfredo Quinones-Hinojosa, M.D. at Mayo Clinic. The trial plans to enroll 100 participants.